Sanofi Adr (SNY)

Apr 30, 2026

Complement Inhibitors Market Outlook Remains Strong During the Forecast Period (2026–2036) with Increasing Adoption of C5 and C3 Targeted Drugs | DelveInsight - GlobeNewswire Inc.

Apr 30, 2026

Apr 29, 2026

Communiqué de presse : Assemblée Générale Annuelle du 29 avril 2026 - GlobeNewswire Inc.

Apr 29, 2026

Apr 29, 2026

SNY Stock Price, Quote & Chart | SANOFI-ADR (NASDAQ:SNY) - ChartMill

Apr 29, 2026

Apr 24, 2026

FDA Approval Broadens Dupixent Use While Sanofi Posts Earnings Beat - Sahm

Apr 24, 2026

Apr 23, 2026

Sanofi Eyes First On-Body Injector Cancer Therapy As FDA Delays Decision - Sahm

Apr 23, 2026

Apr 23, 2026

Earnings call transcript: Sanofi’s Q1 2026 earnings beat forecasts, stock rises - Investing.com

Apr 23, 2026

Apr 23, 2026

Earnings call transcript: Sanofi’s Q1 2026 earnings beat forecasts, stock rises By Investing.com - Investing.com Canada

Apr 23, 2026

Apr 19, 2026

Sanofi S.A. stock (FR0000127771): Is its biopharma pivot strong enough to unlock new upside? - AD HOC NEWS

Apr 19, 2026

Apr 15, 2026

Sanofi ADS (SNY) In-Depth Look | Sanofi ADS posts 4.6% EPS beat on pharma revenueADR - Newser

Apr 15, 2026

Apr 13, 2026

Sanofi S.A. stock (FR0000127771): Is its immunology pipeline strong enough to unlock new upside? - AD HOC NEWS

Apr 13, 2026

Apr 10, 2026

SNY Earnings History & Surprises | EPS & Revenue Results | SANOFI-ADR (NASDAQ:SNY) - ChartMill

Apr 10, 2026

Apr 07, 2026

Sanofi (SNY) Stock Price, News, Quote & History - Yahoo! Finance Canada

Apr 07, 2026

Mar 31, 2026

Morgan Stanley lowers Sanofi stock price target on FX update - Investing.com UK

Mar 31, 2026

Mar 31, 2026

Morgan Stanley lowers Sanofi stock price target on FX update By Investing.com - Investing.com Canada

Mar 31, 2026

Mar 27, 2026

AstraZeneca Strengthens Position In COPD Race With Successful Trials - Sahm

Mar 27, 2026

Mar 25, 2026

Sanofi ADR (NASDAQ:SNY) Presents a Classic Value Investment Case - ChartMill

Mar 25, 2026

Mar 24, 2026

Sanofi S.A. stock faces pressure amid dividend payout and sector headwinds on Euronext Paris - AD HOC NEWS

Mar 24, 2026

Mar 21, 2026

Medicare Chief Chris Klomp Optimistic On CDC Director Search As Vaccine Fight Roils Agency— 'We Will Select...' - Sahm

Mar 21, 2026

Mar 17, 2026

Federal Judge Flags Legal Flaws In RFK Jr.'s Vaccine Overhaul - Sahm

Mar 17, 2026

Mar 11, 2026

Sanofi (NASDAQ:SNY) Emerges as a Top Dividend Stock from Methodical Screening - ChartMill

Mar 11, 2026

Mar 10, 2026

Dupixent Leads the Charge for Sanofi's Strong Portfolio in Immunology, Vaccines, and Rare Diseases - Morningstar

Mar 10, 2026

Mar 02, 2026

MRNA Stock Gains After CHMP Endorses COVID-19-Influenza Combo Shot - Finviz

Mar 02, 2026

Mar 02, 2026

Antibiotics Market - GlobeNewswire Inc.

Mar 02, 2026

Mar 01, 2026

Sanofi (SNY) and Regeneron's Dupixent Recommended for EU Approval - Finviz

Mar 01, 2026

Feb 27, 2026

Kymera Q4 Loss Wider Than Expected, Cash Boost Extends Runway - Finviz

Feb 27, 2026

Feb 27, 2026

DNLI Q4 Loss Narrower Than Expected, Hunter Syndrome Drug in Focus - Finviz

Feb 27, 2026

Feb 27, 2026

Novavax Stock Gains as Q4 Earnings & Sales Beat Estimates - Finviz

Feb 27, 2026

Feb 26, 2026

How Do Investors Really Feel About Sanofi SA? - Sahm

Feb 26, 2026

Feb 25, 2026

CYTK Posts a Wider-Than-Expected Q4 Loss, Advances Myqorzo Launch Plans - Finviz

Feb 25, 2026